In vitro and in vivo studies indicate that while activated NDPP is an efficient sensitizer of hypoxic mammalian cells in vitro, far better than Ro-07-0582 on a molar basis, the situation is reversed in vivo. Determinations of uptake of radioactive drug indicate that activated NDPP is capable of rapidly accumulating in mammalian cells, but no such effect is seen with Ro-07-0582. The uptake of activated NDPP shows a strong dependence on the cell density, whereas the uptake of Ro-07-0582 is little affected by cell density. These results suggest that the high sensitizing efficiency of activated NDPP is due to its ability to be concentrated by cells in a form which is still capable of sensitization and that the cell density effect is largely due to the depletion of the activated form or forms of NDPP. Evidence is also presented that activated NDPP reacts with cellular constituents, notably sulfhydryl compounds, and that the reaction with glutathione produces a compound which is capable of hypoxic cell sensitization. Such reaction products, which are resistant to washing, may explain the pretreatment sensitization produced by activated NDPP.
Skip Nav Destination
Close
Article navigation
1 July 1977
Research Article|
July 01 1977
A Comparison of Radiation-Sensitizing Ability and Cell Uptake for NDPP and Ro-07-0582
Radiat Res (1977) 71 (1): 132–148.
Citation
Thomas W. Wong, Gordon F. Whitmore; A Comparison of Radiation-Sensitizing Ability and Cell Uptake for NDPP and Ro-07-0582. Radiat Res 1 July 1977; 71 (1): 132–148. doi: https://doi.org/10.2307/3574718
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner